Skip to main content
Erschienen in: Cardiovascular Toxicology 3/2018

30.01.2018

A Fatal Case of Amlodipine Toxicity Following Iatrogenic Hypercalcemia

verfasst von: Narges-Sadat Zahed, Hossein Hassanian-Moghaddam, Nasim Zamani

Erschienen in: Cardiovascular Toxicology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Using calcium salts in management of amlodipine overdose is challenging. A 25-year-old male with known history of adult polycystic kidney disease presented with hypotension, tachycardia, and intact neurological status after ingestion of 450 mg of amlodipine. Immediately, normal saline infusion and norepinephrine were initiated. Two grams of calcium gluconate was injected, followed by intravenous infusion of 1.16 mg/kg/h. The patient was put on insulin–glucose protocol to maintain euglycemia and hyperinsulinemia. Electrocardiography demonstrated junctional rhythm. Serum creatinine was 2.5 mg/dL with metabolic acidosis. By the end of 24 h post-admission, his consciousness, blood pressure, and urine output were normal. Almost 32 h post-admission, he became disoriented and his oxygen saturation decreased and therefore was mechanically ventilated. Second chest X-ray showed pulmonary edema. Serum calcium level increased to 26.1 mg/dL. Calcium was discontinued, and furosemide infusion and calcitonin were intravenously administrated. Urine output increased and hemodialysis improved pulmonary edema and serum calcium level with no change in consciousness. Three days after admission, the patient became anuric and developed multi-organ failure and died 5 days post-admission. To avoid the consequences of excessive infusion of calcium in renal failure patients, the minimum calcium dose with close monitoring is recommended.
Literatur
2.
Zurück zum Zitat Watson, W. A., Litovitz, T. L., Klein-Schwartz, W., Rodgers, G. C., Youniss, J., Reid, N., et al. (2004). 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System1. The American Journal of Emergency Medicine, 22, 335–404.CrossRefPubMed Watson, W. A., Litovitz, T. L., Klein-Schwartz, W., Rodgers, G. C., Youniss, J., Reid, N., et al. (2004). 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System1. The American Journal of Emergency Medicine, 22, 335–404.CrossRefPubMed
3.
Zurück zum Zitat Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015). The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacological Reviews, 67, 821–870.CrossRefPubMedPubMedCentral Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015). The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacological Reviews, 67, 821–870.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Shenoy, S., Lankala, S., & Adigopula, S. (2014). Management of calcium channel blocker overdoses. Journal of Hospital Medicine, 9, 663–668.CrossRefPubMed Shenoy, S., Lankala, S., & Adigopula, S. (2014). Management of calcium channel blocker overdoses. Journal of Hospital Medicine, 9, 663–668.CrossRefPubMed
5.
Zurück zum Zitat Sim, M. T., & Stevenson, F. T. (2008). A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose. Journal of Medical Toxicology, 4, 25–29.CrossRefPubMedPubMedCentral Sim, M. T., & Stevenson, F. T. (2008). A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose. Journal of Medical Toxicology, 4, 25–29.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hamdi, H., Hassanian-Moghaddam, H., Hamdi, A., & Zahed, N. (2016). Acid-base disturbances in acute poisoning and their association with survival. Journal of Critical Care, 35, 84–89.CrossRefPubMed Hamdi, H., Hassanian-Moghaddam, H., Hamdi, A., & Zahed, N. (2016). Acid-base disturbances in acute poisoning and their association with survival. Journal of Critical Care, 35, 84–89.CrossRefPubMed
7.
Zurück zum Zitat Deroos, F. J. (2011). Calcium channel blockers. In L. S. Nelson, N. A. Lewin, M. A. Howland, R. S. Hoffman, L. R. Goldfrank, & N. E. Fomenbaum (Eds.), Goldfrank’s toxicologic emergencies (pp. 884–893). New York: Mc Graw Hill. Deroos, F. J. (2011). Calcium channel blockers. In L. S. Nelson, N. A. Lewin, M. A. Howland, R. S. Hoffman, L. R. Goldfrank, & N. E. Fomenbaum (Eds.), Goldfrank’s toxicologic emergencies (pp. 884–893). New York: Mc Graw Hill.
8.
Zurück zum Zitat St-Onge, M., Dube, P. A., Gosselin, S., Guimont, C., Godwin, J., Archambault, P. M., et al. (2014). Treatment for calcium channel blocker poisoning: A systematic review. Clinical Toxicology, 52, 926–944.CrossRefPubMedPubMedCentral St-Onge, M., Dube, P. A., Gosselin, S., Guimont, C., Godwin, J., Archambault, P. M., et al. (2014). Treatment for calcium channel blocker poisoning: A systematic review. Clinical Toxicology, 52, 926–944.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hassanian-Moghaddam, H., & Zamani, N. (2016). Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine (Baltimore), 95, e4349.CrossRef Hassanian-Moghaddam, H., & Zamani, N. (2016). Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine (Baltimore), 95, e4349.CrossRef
11.
Zurück zum Zitat Rietjens, S. J., de Lange, D. W., Donker, D. W., & Meulenbelt, J. (2016). Practical recommendations for calcium channel antagonist poisoning. The Netherlands Journal of Medicine, 74, 60–67.PubMed Rietjens, S. J., de Lange, D. W., Donker, D. W., & Meulenbelt, J. (2016). Practical recommendations for calcium channel antagonist poisoning. The Netherlands Journal of Medicine, 74, 60–67.PubMed
12.
Zurück zum Zitat Hassanian-Moghaddam, H., Zamani, N., Rahimi, M., Hajesmaeili, M., Taherkhani, M., & Sadeghi, R. (2016). Successful treatment of aluminium phosphide poisoning by extracorporeal membrane oxygenation. Basic & Clinical Pharmacology & Toxicology, 118, 243–246.CrossRef Hassanian-Moghaddam, H., Zamani, N., Rahimi, M., Hajesmaeili, M., Taherkhani, M., & Sadeghi, R. (2016). Successful treatment of aluminium phosphide poisoning by extracorporeal membrane oxygenation. Basic & Clinical Pharmacology & Toxicology, 118, 243–246.CrossRef
13.
Zurück zum Zitat Garg, S. K., Goyal, P. K., Kumar, R., Juneja, D., Bhasin, A., & Singh, O. (2014). Management of life-threatening calcium channel blocker overdose with continuous veno-venous hemodiafiltration with charcoal hemoperfusion. Indian Journal of Critical Care Medicine, 18, 399–401.CrossRefPubMedPubMedCentral Garg, S. K., Goyal, P. K., Kumar, R., Juneja, D., Bhasin, A., & Singh, O. (2014). Management of life-threatening calcium channel blocker overdose with continuous veno-venous hemodiafiltration with charcoal hemoperfusion. Indian Journal of Critical Care Medicine, 18, 399–401.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hassanian-Moghaddam, H., & Zamani, N. (2017). Suicide in Iran: The facts and the figures from nationwide reports. Iranian Journal of Psychiatry, 12(1), 73–77.PubMedPubMedCentral Hassanian-Moghaddam, H., & Zamani, N. (2017). Suicide in Iran: The facts and the figures from nationwide reports. Iranian Journal of Psychiatry, 12(1), 73–77.PubMedPubMedCentral
Metadaten
Titel
A Fatal Case of Amlodipine Toxicity Following Iatrogenic Hypercalcemia
verfasst von
Narges-Sadat Zahed
Hossein Hassanian-Moghaddam
Nasim Zamani
Publikationsdatum
30.01.2018
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 3/2018
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-018-9445-3

Weitere Artikel der Ausgabe 3/2018

Cardiovascular Toxicology 3/2018 Zur Ausgabe